Interestingly, our own data suggest that low dose, local tumor necrosis factor alpha (TNFα) acts in a similar manner by re-educating macrophages to release inflammatory and angiogenic modulators which in turn remodel blood vessels and support anti-tumor immunity [66]. The gene discussed is TNF; the disease is neoplasm.